文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型冠状病毒感染相关急性呼吸窘迫综合征接受静脉-静脉体外膜肺氧合患者的膈肌功能

Diaphragm function in patients with Covid-19-related acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation.
PubMed 文献 · Ann Intensive Care · 2023-09-26
一句话结论接受VV ECMO的COVID-19相关ARDS患者中,62%在ECMO启动第1天即存在膈肌功能障碍,且一周内功能稳定,与自主呼吸时间百分比无关。

该研究在两家中心纳入63例因ARDS需要VV ECMO的患者,在ECMO启动(第1天)至脱机期间通过膈神经刺激测气管压力(Ptr,stim)系列评估膈肌功能,并以自主呼吸通气百分比和超声膈肌增厚分数(TFdi)估计膈肌活动。结果显示,以Ptr,stim ≤ 11 cmH2O定义膈肌功能障碍,第1天有39例(62%)存在功能障碍;研究期间膈肌功能无变化,且不受1周内自主呼吸通气百分比或TFdi影响。63例中24例(38%)在研究期结束(60天)时仍存活。

要点

  • 63例COVID-19相关ARDS接受VV ECMO患者中,第1天62%(39例)存在膈肌功能障碍(Ptr,stim ≤ 11 cmH2O)。
  • 膈肌功能在研究期间无变化,且不受1周内自主呼吸通气百分比或TFdi影响。
  • 63例中38%(24例)在研究期结束(60天)时仍存活。
  • 纳入时中位有创机械通气时间为4天(3-6天)。

适用人群与场景

  • 两家中心纳入的因ARDS需要VV ECMO的患者,纳入时中位有创机械通气4天(3-6天)。

诊断标准与关键阈值

  • 膈肌功能障碍定义为膈神经刺激时气管压力(Ptr,stim)≤ 11 cmH2O。

研究设计与关键结果

  • 研究类型为在两家中心开展的前瞻性研究,纳入63例因ARDS接受VV ECMO的患者,从ECMO启动(第1天)至脱机系列评估膈肌功能。
  • 第1天有39例(62%)存在膈肌功能障碍(Ptr,stim ≤ 11 cmH2O)。
  • 膈肌功能在研究期间无变化,且1周内不受自主呼吸通气百分比或TFdi影响。
  • 63例中24例(38%)在研究期结束(60天)时仍存活。

证据类型、等级与局限

  • 证据类型:在两家中心开展的前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,VV ECMO患者膈肌功能障碍患病率高,且膈肌功能随时间保持稳定,与自主呼吸时间百分比无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Venovenous extracorporeal membrane oxygenation (VV ECMO) is frequently associated with deep sedation and neuromuscular blockades, that may lead to diaphragm dysfunction. However, the prevalence, risk factors, and evolution of diaphragm dysfunction in patients with VV ECMO are unknown. We hypothesized that the prevalence of diaphragm dysfunction is high and that diaphragm activity influences diaphragm function changes.

METHODS: Patients with acute respiratory distress syndrome (ARDS) requiring VV ECMO were included in two centers. Diaphragm function was serially assessed by measuring the tracheal pressure in response to phrenic nerve stimulation (Ptr,stim) from ECMO initiation (Day 1) until ECMO weaning. Diaphragm activity was estimated from the percentage of spontaneous breathing ventilation and by measuring the diaphragm thickening fraction (TFdi) with ultrasound.

RESULTS: Sixty-three patients were included after a median of 4 days (3-6) of invasive mechanical ventilation. Diaphragm dysfunction, defined by Ptr, stim ≤ 11 cmH2O, was present in 39 patients (62%) on Day 1 of ECMO. Diaphragm function did not change over the study period and was not influenced by the percentage of spontaneous breathing ventilation or the TFdi during the 1 week. Among the 63 patients enrolled in the study, 24 (38%) were still alive at the end of the study period (60 days).

CONCLUSIONS: Sixty-two percent of patients undergoing ECMO for ARDS related to SARS CoV-2 infection had a diaphragm dysfunction on Day 1 of ECMO initiation. Diaphragm function remains stable over time and was not associated with the percentage of time with spontaneous breathing.

CLINICALTRIALS: gov Identifier NCT04613752 (date of registration February 15, 2021).

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Gautier M, Joussellin V, Ropers J, et al. Diaphragm function in patients with Covid-19-related acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation. Ann Intensive Care. 2023. PMID: 37752337. doi:10.1186/s13613-023-01179-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。